JBT Marel Corporation

JBTM

CIK 0001433660 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$2.51B
↑+487.0% +$2.08Bvs FY2024 (Q4)
Operating Income
$72M
↑+360.5% +$57Mvs FY2024 (Q4)
Net Income
$57M
↑+667.6% +$49Mvs FY2024 (Q4)
Gross Profit
$1.85B
↑+1227.0% +$1.71Bvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
41/100
  • Profitability
    0ROIC 3.4% (10% = solid, 20%+ = moat)
  • Liquidity
    24Current Ratio 0.98 (above 1.5 = solid)
  • Leverage
    84D/E 0.33 (under 0.5 = conservative)
  • Efficiency
    35Asset Turnover 0.65x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +487.0% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Op Margin 2.9% · trend -3.4pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project JBTM's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

25%

Trailing 3-yr CAGR was 67.6%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$152.73
Total enterprise IV
$7.94B
Diluted shares
0.05B
Terminal PV
$6.17B (78% of total)
Year-5 FCF
$727M
YearProjected FCFDiscounted PV
+1$298M$271M
+2$372M$307M
+3$465M$349M
+4$581M$397M
+5$727M$451M
Terminal$9.93B$6.17B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$104M
investment in PP&E
Dividends paid (TTM)
$21M
cash returned to holders
Stock buybacks (TTM)
$0
share count reduction
Stock-based comp (TTM)
$23M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$8.19B
everything owned
Stockholders' equity
$4.46B
shareholder claim
Net debt
$1.30B
LT debt minus cash

Recent performance · 64 quarters

Revenue↑+487.0% +$2.08B
$2.51B
Net Income↑+69.7% +$27M
$66M
Free Cash Flow↓-29.7% -$35M
$84M
Operating Margin↓-0.8pts
2.9%

Drill down